The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT05391802

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05391802
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05391802. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-30 (anticipated); primary completion 2022-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial)
Condition
Mitral Regurgitation
Intervention (Device)
Transcatheter mitral valve repair
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct05391802
Content hash
c21cd598248c6ee7b6bc4950480d13980433649e2a7a85af3d56fd41eb003470